Cited by 724Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes and associated disorders

Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes

Open access
Laing, S. P., Swerdlow, A. J., Slater, S. D., Burden, A. C., Morris, A., Waugh, N. R., Gatling, W., Bingley, P. J. +1 more·2003·Diabetologia

Abstract

Aims/hypothesis Although ischaemic heart disease is the predominant cause of mortality in older people with diabetes, age-specific mortality rates have not been published for patients with Type 1 diabetes. The Diabetes UK cohort, essentially one of patients with Type 1 diabetes, now has sufficient follow-up to report all heart disease, and specifically ischaemic heart disease, mortality rates by age.Methods A cohort of 23,751 patients with insulin-treated diabetes, diagnosed under the age of 30 years and from throughout the United Kingdom, was identified during the period 1972 to 1993 and followed for mortality until December 2000. Age- and sex-specific heart disease mortality rates and standardised mortality ratios were calculated.Results There were 1437 deaths during the follow-up, 536 from cardiovascular disease, and of those, 369 from ischaemic heart disease. At all ages the ischaemic heart disease mortality rates in the cohort were higher than in the general population. Mortality rates within the cohort were similar for men and women under the age of 40. The standardised mortality ratios were higher in women than men at all ages, and in women were 44.8 (95%CI 20.5-85.0) at ages 20-29 and 41.6 (26.7-61.9) at ages 30-39.Conclusions/interpretation The risk of mortality from ischaemic heart disease is exceptionally high in young adult women with Type 1 diabetes, with rates similar to those in men with Type 1 diabetes under the age of 40. These observations emphasise the need to identify and treat coronary risk factors in these young patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-003-1116-6

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hypertension, dyslipidaemia, abdominal obesity, and non-alcoholic fatty liver disease commonly coexist with type 2 diabetes and further aggravate risk, which is highest in those with multiple cardiometabolic risk factors.

    “Hypertension, dyslipidaemia, abdominal obesity, and non-alcoholic fatty liver disease (NAFLD) commonly coexist with T2DM and further aggravate the risk, which is highest in people with T2DM and multiple cardiometabolic risk factors [406-408].”
  • Type 1 diabetes is associated with high CVD risk, particularly in patients with microalbuminuria and renal disease.

    “Type 1 diabetes is associated with high CVD risk, in particular in patients with microalbuminuria and renal disease.177”

    From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [177]

  • Type 1 diabetes is associated with high CVD risk, particularly in patients with microalbuminuria and renal disease.

    “Type 1 diabetes is associated with high CVD risk, in particular in patients with microalbuminuria and renal disease. 355”

    From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [355]

  • Type 1 diabetes is associated with high cardiovascular disease risk, particularly in patients with microalbuminuria and renal disease.

    “Type 1 diabetes is associated with high CVD risk, in particular in patients with microalbuminuria and renal disease.355”

    From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [355]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Laing, S. P., Swerdlow, A. J., Slater, S. D., Burden, A. C., Morris, A., Waugh, N. R., Gatling, W., Bingley, P. J., & Patterson, C. C.
Affiliations
  • Institute of Cancer Research (GB)
  • Glasgow Victoria Infirmary (GB)
  • University of Leicester (GB)
  • University of Dundee (GB)
  • University of Aberdeen (GB)
  • Poole Hospital (GB)
  • University of Bristol (GB)
  • Queen's University Belfast (GB)
Corresponding author
Laing, S. P.
Venue
Diabetologia
Published
2003-06-01
Volume
46
Issue
6
Pages
760-765
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2004673584
Cited by
724
References
31
Citations by year
2026: 4 · 2025: 10 · 2024: 20 · 2023: 19 · 2022: 14 · 2021: 26 · 2020: 28 · 2019: 40 · 2018: 44 · 2017: 46 · 2016: 46 · 2015: 54 · 2014: 63 · 2013: 56 · 2012: 45
FWCI
8.83
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Royal College of Physicians of Edinburgh
  • Diabetes UK
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
type 1 diabetes, ischemic heart disease, cardiovascular mortality, insulin-treated diabetes, young adult women, sex differences in mortality, age-specific mortality, standardized mortality ratio, coronary risk factors
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Child, Diabetes Mellitus, Type 1, Diabetic Angiopathies, Female, United Kingdom, Heart Diseases, Humans, Male, Middle Aged, Registries, Sex Characteristics, Cohort Studies, Myocardial Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review